Skip to content

Vivani Medical VANI Q4 2024 Annual earnings

Reported March 31, 2025 · Before market open

Next report

Aug 12, 2026 (In 3 weeks)
EPS estimate-$0.08

Financials

Q4 2024

Income statement

See full
Revenue-
Operating income-$6.5M-3.9%
Net income-$6.1M-0.4%
EPS (diluted)-$0.110.0%

Balance sheet

See full
Cash & equivalents$19.7M-10.5%
Total debt$19.3M-6.7%
Total equity$17.6M-15.2%
Total assets$41.6M-9.2%

Cash flow

See full
Operating cash flow-$5.8M-67.0%
CapEx$296.0K-60.2%
Free cash flow-$6.1M-44.6%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$68.71M+32.0%
Enterprise value$68.34M+34.7%

Returns & leverage

See full
Return on equity-122.4%+151pp
Debt / equity1.1×+0.1×
Current ratio3.4×-0.6×

Versus estimates

Ask the moment Vivani Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Vivani Medical report Q4 2024 earnings?
Vivani Medical (VANI) reported Q4 2024 earnings on March 31, 2025 before market open.
What were Vivani Medical's Q4 2024 revenue and EPS?
Vivani Medical reported revenue of $398.0K and diluted EPS of $-0.11 for Q4 2024.
Did Vivani Medical beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.10 by $0.01.
Where can I find Vivani Medical's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001753926-25-000527) directly on SEC EDGAR. The filing index links above go to sec.gov.